Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital ; volume:12 ; number:4 ; day:15 ; month:8 ; year:2008 ; pages:1-7 ; date:8.2008
Critical care ; 12, Heft 4 (15.8.2008), 1-7, 8.2008
- Creator
-
Bruce, David
- Contributor
-
Nokes, Tim JC
SpringerLink (Online service)
- DOI
-
10.1186/cc6987
- URN
-
urn:nbn:de:1111-2016080820748
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bruce, David
- Nokes, Tim JC
- SpringerLink (Online service)
Other Objects (12)
Preparation of a Nonthrombogenic Prothrombin Complex Concentrate
Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding
3-Factor prothrombin complex concentrate versus 4-factor prothrombin complex concentrate for the reversal of oral factor Xa inhibitors
Erratum to: Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study
Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery
Role of prothrombin complex concentrate in perioperative coagulation therapy
Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
Long-Term Safety of a Four-Factor Prothrombin Complex Concentrate (Kcentra®/Beriplex® P/N): An Updated Pharmacovigilance Review
Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding
Theoretical Modeling of Coagulation Management With Therapeutic Plasma or Prothrombin Complex Concentrate
Thrombin Generation Capacity of Prothrombin Complex Concentrate in an In Vitro Dilutional Model
Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM®)-guided administration of fibrinogen concentrate and prothrombin complex concentrate
Preparation of a Nonthrombogenic Prothrombin Complex Concentrate
Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding
3-Factor prothrombin complex concentrate versus 4-factor prothrombin complex concentrate for the reversal of oral factor Xa inhibitors
Erratum to: Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study
Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery
Role of prothrombin complex concentrate in perioperative coagulation therapy
Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
Long-Term Safety of a Four-Factor Prothrombin Complex Concentrate (Kcentra®/Beriplex® P/N): An Updated Pharmacovigilance Review
Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding
Theoretical Modeling of Coagulation Management With Therapeutic Plasma or Prothrombin Complex Concentrate
Thrombin Generation Capacity of Prothrombin Complex Concentrate in an In Vitro Dilutional Model
Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM®)-guided administration of fibrinogen concentrate and prothrombin complex concentrate
Preparation of a Nonthrombogenic Prothrombin Complex Concentrate
Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding
3-Factor prothrombin complex concentrate versus 4-factor prothrombin complex concentrate for the reversal of oral factor Xa inhibitors
Erratum to: Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study
Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery
Role of prothrombin complex concentrate in perioperative coagulation therapy
Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
Long-Term Safety of a Four-Factor Prothrombin Complex Concentrate (Kcentra®/Beriplex® P/N): An Updated Pharmacovigilance Review
Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding
Theoretical Modeling of Coagulation Management With Therapeutic Plasma or Prothrombin Complex Concentrate
Thrombin Generation Capacity of Prothrombin Complex Concentrate in an In Vitro Dilutional Model